Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,916,629
-
Total 13F shares
-
32,251,087
-
Share change
-
+4,581,388
-
Total reported value
-
$208,968,732
-
Put/Call ratio
-
1458%
-
Price per share
-
$6.48
-
Number of holders
-
59
-
Value change
-
+$29,830,206
-
Number of buys
-
38
-
Number of sells
-
16
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q1 2024
As of 31 Mar 2024,
Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,251,087 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MPM BIOIMPACT LLC, BANK OF AMERICA CORP /DE/, JANUS HENDERSON GROUP PLC, Rubric Capital Management LP, VANGUARD GROUP INC, and Monashee Investment Management LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.